Jiao-tai-wan for insomnia symptoms caused by the disharmony of the heart and kidney: a study protocol for a randomized, double-blind, placebo-controlled trial
Open Access
- 15 May 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Trials
- Vol. 21 (1), 1-9
- https://doi.org/10.1186/s13063-020-04299-x
Abstract
Insomnia seriously affects people’s normal lives and work. However, effective treatment strategies are scarce. The purpose of this study is to explore the efficacy and safety of Jiao-tai-wan (JTW) for ameliorating insomnia symptoms caused by disharmony of the heart and kidney. This is a randomized, double-blind, placebo-controlled pilot clinical trial. A total of 124 participants suffering from insomnia symptoms will be randomly assigned to the JTW or placebo group in an equal ratio. The participants will be asked to take JTW or placebo granules twice a day for 1 week. All data will be gathered at baseline and at the end of the drug intervention. The primary outcome measures will be the mean change in the Pittsburgh Sleep Quality Index (PSQI) from baseline to the end of the drug intervention. Secondary outcome measures will include the altered sleep parameters in polysomnography, 1H-magnetic resonance spectroscopy (1H-MRS) evaluation, the Disharmony of Heart and Kidney Scoring System score, and blood tests, including the levels of serum adenosine and melatonin. A laboratory test will be taken before and after treatment to assess the safety of JTW. The outcomes of this study will confirm the efficacy of JTW for the treatment of insomnia symptoms and will also be used to monitor the safety of JTW. Chinese Clinical Trial Registry, ChiCTR1 800019239. Registered on 1st November 2018.Other Versions
Funding Information
- National Natural Science Foundation of China (81673733)
This publication has 23 references indexed in Scilit:
- Melatonin: functions and ligandsDrug Discovery Today, 2014
- The Insomnia Severity Index: cross-cultural adaptation and psychometric evaluation of a Persian versionQuality of Life Research, 2013
- SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical TrialsAnnals of Internal Medicine, 2013
- Chinese herbal medicine for insomnia: A systematic review of randomized controlled trialsSleep Medicine Reviews, 2012
- Classification of Insomnia Using the Traditional Chinese Medicine System: A Systematic ReviewEvidence-Based Complementary and Alternative Medicine, 2012
- Influence of work shift on glutamic acid and gamma-aminobutyric acid (GABA): Evaluation with proton magnetic resonance spectroscopy at 3TPsychiatry Research: Neuroimaging, 2011
- The FLEP scale in diagnosing nocturnal frontal lobe epilepsy, NREM and REM parasomnias: Data from a tertiary sleep and epilepsy unitEpilepsia, 2008
- 1H MR Spectroscopy of the Brain: Absolute Quantification of MetabolitesRadiology, 2006
- Measures of sleep: The Insomnia Severity Index, Medical Outcomes Study (MOS) Sleep Scale, Pittsburgh Sleep Diary (PSD), and Pittsburgh Sleep Quality Index (PSQI)Arthritis & Rheumatism, 2003
- The Pittsburgh sleep quality index: A new instrument for psychiatric practice and researchPsychiatry Research, 1989